Compare
5 stocks, side by sideRelative performance · rebased to 100
RGCKNSAINDVSUPNBCRX
| RGCRegencell Bioscience Holdings Limited | KNSAKiniksa Pharmaceuticals International, plc | INDVIndivior Pharmaceuticals, Inc. | SUPNSupernus Pharmaceuticals, Inc. | BCRXBioCryst Pharmaceuticals, Inc. | |
|---|---|---|---|---|---|
| Smart Score | 1/10 | 6/10 | 5/10 | 6/10 | 1/10 |
| Price | $6.81 | $77.16 | $34.32 | $42.43 | $9.07 |
| 1 month | +25% | +0.88% | -11% | -9.3% | -2.5% |
| 1 year | -49% | +129% | +47% | -1.3% | +8.2% |
| 5 year | +2835% | +520% | +186% | +73% | -42% |
| P/E (TTM) | -2.0 | 84.8 | 17.6 | -83.2 | -5.1 |
| P/E vs sector | - | +184% | -41% | - | - |
| Market cap | $3.7B | $4.4B | $4.9B | $2.6B | $2.5B |
| Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.